Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.63 Million USD | 99.93% |
| 2022 | -13.17 Million USD | -17.35% |
| 2021 | -11.28 Million USD | -25.05% |
| 2020 | -9.02 Million USD | -26.06% |
| 2019 | -7.15 Million USD | 0.56% |
| 2018 | -7.19 Million USD | -127.58% |
| 2017 | -5.24 Million USD | 68.16% |
| 2016 | -9.62 Million USD | 72.87% |
| 2015 | -897 Thousand USD | -18.51% |
| 2014 | -29.65 Million USD | 2.65% |
| 2013 | -24.21 Million USD | -50.05% |
| 2012 | -27.44 Million USD | 35.91% |
| 2011 | -20.04 Million USD | -4.5% |
| 2010 | -23.62 Million USD | -4.98% |
| 2009 | -25.22 Million USD | -44.77% |
| 2008 | -27.79 Million USD | 23.28% |
| 2007 | -23.72 Million USD | -37.46% |
| 2006 | -17.76 Million USD | -5.65% |
| 2005 | -10.48 Million USD | -38.44% |
| 2004 | -14.1 Million USD | -20.74% |
| 2003 | -11.13 Million USD | -14.18% |
| 2002 | -9.8 Million USD | 44.59% |
| 2001 | -9.69 Million USD | -284.02% |
| 2000 | -6.48 Million USD | -155.73% |
| 1999 | -7.84 Million USD | 85.04% |
| 1998 | -10.69 Million USD | -39.53% |
| 1997 | -12.1 Million USD | 47.88% |
| 1996 | -13.9 Million USD | -205.56% |
| 1995 | -6 Million USD | 66.46% |
| 1994 | -15.1 Million USD | -50.47% |
| 1993 | -10.7 Million USD | -20.22% |
| 1992 | -8.9 Million USD | -43.55% |
| 1991 | -6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.49 Million USD | -5.98% |
| 2024 Q1 | -2.35 Million USD | -15.89% |
| 2023 Q1 | -2.89 Million USD | 4.65% |
| 2023 FY | - USD | 26.36% |
| 2023 Q4 | -2.03 Million USD | 19.45% |
| 2023 Q2 | -2.29 Million USD | 20.59% |
| 2023 Q3 | -2.52 Million USD | -9.83% |
| 2022 FY | - USD | -17.35% |
| 2022 Q4 | -3.03 Million USD | 12.0% |
| 2022 Q3 | -3.44 Million USD | 2.57% |
| 2022 Q2 | -3.54 Million USD | -12.2% |
| 2022 Q1 | -3.15 Million USD | 19.29% |
| 2021 FY | - USD | -25.05% |
| 2021 Q1 | -2.37 Million USD | 9.11% |
| 2021 Q2 | -2.46 Million USD | -3.71% |
| 2021 Q3 | -2.53 Million USD | -3.01% |
| 2021 Q4 | -3.9 Million USD | -54.14% |
| 2020 Q1 | -2.14 Million USD | -15.87% |
| 2020 FY | - USD | -26.06% |
| 2020 Q4 | -2.61 Million USD | -9.02% |
| 2020 Q3 | -2.39 Million USD | -28.33% |
| 2020 Q2 | -1.86 Million USD | 13.0% |
| 2019 Q1 | -1.9 Million USD | 8.37% |
| 2019 Q3 | -1.77 Million USD | -15.74% |
| 2019 FY | - USD | 0.56% |
| 2019 Q4 | -1.85 Million USD | -4.51% |
| 2019 Q2 | -1.53 Million USD | 19.63% |
| 2018 Q2 | -1.87 Million USD | -24.85% |
| 2018 FY | - USD | -127.58% |
| 2018 Q1 | -1.5 Million USD | 1.7% |
| 2018 Q4 | -2.07 Million USD | -20.38% |
| 2018 Q3 | -1.72 Million USD | 8.09% |
| 2017 FY | - USD | 68.16% |
| 2017 Q1 | -1.32 Million USD | 36.77% |
| 2017 Q2 | -1.25 Million USD | 5.06% |
| 2017 Q3 | -1.23 Million USD | 1.91% |
| 2017 Q4 | -1.53 Million USD | -24.27% |
| 2016 Q2 | 3.84 Million USD | 140.3% |
| 2016 Q1 | -9.53 Million USD | -30.24% |
| 2016 FY | - USD | 72.87% |
| 2016 Q4 | -2.09 Million USD | -11.66% |
| 2016 Q3 | -1.87 Million USD | -148.77% |
| 2015 FY | - USD | -18.51% |
| 2015 Q2 | -9.02 Million USD | -5.61% |
| 2015 Q1 | -8.54 Million USD | 11.1% |
| 2015 Q3 | -9.66 Million USD | -7.1% |
| 2015 Q4 | -7.32 Million USD | 24.28% |
| 2014 Q4 | -9.61 Million USD | 9.22% |
| 2014 Q1 | -6.57 Million USD | 46.52% |
| 2014 Q3 | -10.59 Million USD | -36.12% |
| 2014 Q2 | -7.78 Million USD | -18.31% |
| 2014 FY | - USD | 2.65% |
| 2013 FY | - USD | -50.05% |
| 2013 Q2 | -5.96 Million USD | -0.12% |
| 2013 Q4 | -12.29 Million USD | -91.96% |
| 2013 Q3 | -6.4 Million USD | -7.46% |
| 2013 Q1 | -5.95 Million USD | 63.92% |
| 2012 Q2 | -11.52 Million USD | -12609.67% |
| 2012 FY | - USD | 35.91% |
| 2012 Q4 | -16.5 Million USD | -345.55% |
| 2012 Q1 | -90.67 Thousand USD | 98.43% |
| 2012 Q3 | 6.72 Million USD | 158.32% |
| 2011 FY | - USD | -4.5% |
| 2011 Q1 | -9.14 Million USD | -45.99% |
| 2011 Q2 | -9.92 Million USD | -8.63% |
| 2011 Q3 | -7.86 Million USD | 20.77% |
| 2011 Q4 | -5.76 Million USD | 26.66% |
| 2010 Q2 | -8.88 Million USD | -6.31% |
| 2010 Q3 | -8.08 Million USD | 9.0% |
| 2010 Q1 | -8.35 Million USD | 27.66% |
| 2010 Q4 | -6.26 Million USD | 22.53% |
| 2010 FY | - USD | -4.98% |
| 2009 Q3 | -8.38 Million USD | -33.17% |
| 2009 FY | - USD | -44.77% |
| 2009 Q1 | -3.84 Million USD | -87.39% |
| 2009 Q4 | -11.54 Million USD | -37.67% |
| 2009 Q2 | -6.29 Million USD | -63.93% |
| 2008 Q4 | -2.05 Million USD | 62.99% |
| 2008 Q3 | -5.54 Million USD | 13.81% |
| 2008 Q2 | -6.42 Million USD | 0.03% |
| 2008 Q1 | -6.43 Million USD | 0.19% |
| 2008 FY | - USD | 23.28% |
| 2007 Q2 | -5.45 Million USD | 25.03% |
| 2007 Q1 | -7.27 Million USD | -19.09% |
| 2007 Q3 | -7.42 Million USD | -36.3% |
| 2007 Q4 | -6.44 Million USD | 13.27% |
| 2007 FY | - USD | -37.46% |
| 2006 FY | - USD | -5.65% |
| 2006 Q1 | -4.05 Million USD | 6.44% |
| 2006 Q4 | -6.1 Million USD | -19.02% |
| 2006 Q3 | -5.12 Million USD | -197.32% |
| 2006 Q2 | 5.27 Million USD | 229.98% |
| 2005 FY | - USD | -38.44% |
| 2005 Q4 | -4.33 Million USD | 40.34% |
| 2005 Q3 | -7.26 Million USD | -98.53% |
| 2005 Q2 | -3.65 Million USD | -7.85% |
| 2005 Q1 | -3.39 Million USD | 13.85% |
| 2004 FY | - USD | -20.74% |
| 2004 Q2 | -3.02 Million USD | -21.18% |
| 2004 Q3 | -4 Million USD | -32.35% |
| 2004 Q4 | -3.93 Million USD | 1.72% |
| 2004 Q1 | -2.49 Million USD | 46.36% |
| 2003 Q1 | -2.1 Million USD | -118.45% |
| 2003 Q4 | -4.66 Million USD | -116.43% |
| 2003 Q3 | -2.12 Million USD | 4.32% |
| 2003 FY | - USD | -14.18% |
| 2003 Q2 | -2.23 Million USD | -7.05% |
| 2002 Q2 | -3.01 Million USD | -9.96% |
| 2002 Q4 | -1.05 Million USD | 64.12% |
| 2002 Q1 | -2.76 Million USD | -42.59% |
| 2002 FY | - USD | 44.59% |
| 2002 Q3 | -2.67 Million USD | 12.28% |
| 2001 Q1 | -2.39 Million USD | -432.15% |
| 2001 Q4 | -2.12 Million USD | -13.79% |
| 2001 FY | - USD | -284.02% |
| 2001 Q3 | -1.65 Million USD | 80.46% |
| 2001 Q2 | -3.51 Million USD | -68.28% |
| 2000 Q2 | -1.78 Million USD | -100.85% |
| 2000 Q3 | -1.76 Million USD | 60.92% |
| 2000 Q4 | -1.38 Million USD | 223.02% |
| 2000 FY | - USD | -155.73% |
| 2000 Q1 | -1.55 Million USD | -121.08% |
| 1999 Q3 | -6 Million USD | -328.57% |
| 1999 FY | - USD | 85.04% |
| 1999 Q1 | -1.49 Million USD | -13.33% |
| 1999 Q2 | -1.4 Million USD | 17.65% |
| 1999 Q4 | 1.25 Million USD | 228.41% |
| 1998 FY | - USD | -39.53% |
| 1998 Q4 | -1.2 Million USD | 46.43% |
| 1998 Q3 | -2.5 Million USD | 33.33% |
| 1998 Q2 | -3.8 Million USD | -13.51% |
| 1998 Q1 | -3.3 Million USD | -138.95% |
| 1997 FY | - USD | 47.88% |
| 1997 Q4 | 4.6 Million USD | 176.61% |
| 1997 Q3 | -12 Million USD | -1140.0% |
| 1997 Q2 | -500 Thousand USD | 78.26% |
| 1997 Q1 | -4.1 Million USD | 0.0% |
| 1996 FY | - USD | -205.56% |
| 1996 Q3 | -3.6 Million USD | -5.0% |
| 1996 Q2 | -3.1 Million USD | -11.11% |
| 1996 Q1 | -3 Million USD | -200.0% |
| 1996 Q4 | -4.1 Million USD | -9.52% |
| 1995 Q2 | -2.8 Million USD | -260.0% |
| 1995 FY | - USD | 66.46% |
| 1995 Q1 | 2.2 Million USD | 144.44% |
| 1995 Q4 | -2.9 Million USD | 57.14% |
| 1995 Q3 | -2.4 Million USD | 12.5% |
| 1994 Q2 | -4.1 Million USD | -59.26% |
| 1994 FY | - USD | -50.47% |
| 1994 Q1 | -2.4 Million USD | 79.39% |
| 1994 Q4 | -4.1 Million USD | -2.27% |
| 1994 Q3 | -4.2 Million USD | -2.33% |
| 1993 Q2 | -3.2 Million USD | 5.88% |
| 1993 Q3 | 200 Thousand USD | 106.25% |
| 1993 Q4 | -13.1 Million USD | -6650.0% |
| 1993 FY | - USD | -20.22% |
| 1993 Q1 | -3.1 Million USD | 68.22% |
| 1992 Q1 | 200 Thousand USD | 102.99% |
| 1992 FY | - USD | -43.55% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 400 Thousand USD | 100.0% |
| 1992 Q4 | -10.7 Million USD | -2775.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q4 | -6.7 Million USD | -6800.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 76.696% |
| AngioDynamics, Inc. | -14.29 Million USD | 25.595% |
| AtriCure, Inc. | -8.1 Million USD | -31.138% |
| Avinger, Inc. | -16.34 Million USD | 34.944% |
| Azenta, Inc. | 55.15 Million USD | 119.282% |
| BioLife Solutions, Inc. | -45.23 Million USD | 76.493% |
| The Cooper Companies, Inc. | 882.8 Million USD | 101.205% |
| Daxor Corporation | 329.74 Thousand USD | 3324.965% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 19.427% |
| Femasys Inc. | -13.16 Million USD | 19.252% |
| GlucoTrack, Inc. | -7.09 Million USD | -49.965% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 212.019% |
| Hologic, Inc. | 1.29 Billion USD | 100.82% |
| ICU Medical, Inc. | 307.69 Million USD | 103.456% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.444% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -13.133% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 121.706% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -61.731% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -61.731% |
| Masimo Corporation | 236.7 Million USD | 104.493% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 167.429% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 104.595% |
| Nephros, Inc. | -1.37 Million USD | -671.139% |
| NovoCure Limited | -175.86 Million USD | 93.953% |
| NEXGEL, Inc. | -2.73 Million USD | -289.524% |
| NEXGEL, Inc. | -2.73 Million USD | -289.524% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 87.706% |
| OraSure Technologies, Inc. | 76.15 Million USD | 113.963% |
| Pro-Dex, Inc. | 8.33 Million USD | 227.613% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 74.9% |
| Predictive Oncology Inc. | -13.18 Million USD | 19.329% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -323.336% |
| QuidelOrtho Corporation | 545.6 Million USD | 101.949% |
| Repligen Corporation | 124.29 Million USD | 108.556% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -3578.35% |
| STAAR Surgical Company | 33.22 Million USD | 132.01% |
| Sharps Technology, Inc. | -8.98 Million USD | -18.414% |
| Utah Medical Products, Inc. | 24.8 Million USD | 142.87% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 104.584% |
| Jin Medical International Ltd. | 3.44 Million USD | 408.869% |